Pubblicazioni per linea Response

24 11, 2014

Marco Chilosi et al., Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis. Leukemia & Lymphoma

Diatech Pharmacogenetics2017-08-08T16:16:33+02:00

11 10, 2014

Virginia Rotella et al., EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition. Journal of Experimental & Clinical Cancer Research

Diatech Pharmacogenetics2022-04-20T12:44:33+02:00

4 08, 2014

Caterina Fumagalli et al., Prevalence and Clinicopathologic Correlates of O6-Methylguanine-DNA Methyltransferase Methylation Status in Patients With Triple-Negative Breast Cancer Treated Preoperatively by Alkylating Drugs. Clinical Breast Cancer

Diatech Pharmacogenetics2022-04-20T12:44:34+02:00

1 07, 2014

Esther Diana Rossi et al., Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience. Cancer Cytopathology

Diatech Pharmacogenetics2022-04-20T12:45:17+02:00

1 06, 2014

Giovanna De Maglio et al., COMPARISON OF A NEW MULTIPLEXED MULTIGENE APPROACH WITH PYROSEQUENCING IN DIAGNOSTIC MOLECULAR BIOLOGY OF COLORECTAL CANCER (CRC). Annals of Oncology

Diatech Pharmacogenetics2022-04-20T12:45:18+02:00

5 05, 2014

Anna Crescenzi et al., Immunohistochemistry for BRAF(V600E) Antibody VE1 Performed in Core Needle Biopsy Samples Identifies Mutated Papillary Thyroid Cancers. Hormone and Metabolic Research

Diatech Pharmacogenetics2022-04-20T12:46:51+02:00

5 05, 2014

Riccardo Giannini et al., KRAS and BRAF genotyping of synchronous colorectal carcinomas. Oncology Letters

Diatech Pharmacogenetics2022-04-20T12:46:51+02:00

15 04, 2014

Alessandro Del Gobbo et al., Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature. International Journal of Clinical & Experimental Pathology

Diatech Pharmacogenetics2022-04-20T12:47:59+02:00

14 04, 2014

Valentina Guarneri et al., Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase IIB Neoadjuvant Study of Letrozole-Lapatinib in Postmenopausal Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Operable Breast Cancer. Journal of Clinical Oncology

Diatech Pharmacogenetics2022-04-20T12:48:00+02:00

14 04, 2014

Daniele Barbaro et al., The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis. Endocrine

Diatech Pharmacogenetics2022-04-20T12:48:02+02:00

Precedente 101112 Successivo